Golden State Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.42K Sell
16
-3
-16% -$1.68K ﹤0.01% 1150
2026
Q1
$10.7K Hold
19
﹤0.01% 1075
2025
Q4
$12.9K Sell
19
-3
-14% -$2.04K ﹤0.01% 1039
2025
Q3
$14.1K Hold
22
﹤0.01% 1007
2025
Q2
$11.8K Buy
22
+17
+340% +$8.13K ﹤0.01% 1033
2025
Q1
$2.1K Buy
5
+2
+67% +$868 ﹤0.01% 1312
2024
Q4
$1.24K Buy
+3
New +$1.32K ﹤0.01% 1326

Other funds holding IDXX

Golden State Wealth Management's IDXX Position: Q2 2026 in Review

Golden State Wealth Management reduced its Idexx Laboratories (IDXX) stake by 16% in Q2 2026, selling an estimated $1.68K and leaving 16 shares worth $8.42K. The position accounts for ﹤0.01% of the portfolio, ranked #1150.

Golden State Wealth Management first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $14.1K in Q3 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Golden State Wealth Management held 16 shares of Idexx Laboratories worth $8.42K as of Q2 2026.
  • Golden State Wealth Management sold 3 Idexx Laboratories shares in Q2 2026, an estimated $1.68K.
  • Idexx Laboratories made up ﹤0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #1150 holding.
  • Golden State Wealth Management first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Golden State Wealth Management's Idexx Laboratories position peaked at $14.1K in Q3 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.